E.U. investigates Ozempic and weight-loss drug Saxenda after reports of suicidal thoughts

The European Medicines Agency is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients thinking about suicide or self-harm.